Skip to main content
. 2022 Jul 1;16:100345. doi: 10.1016/j.mtbio.2022.100345

Fig. 9.

Fig. 9

SARS-CoV-2-infected lung organoids. Immunofluorescence images of (A) bronchiolar and (B) bronchial organoids pretreated with Camostat [120]. (C) Inhibition of SARS-CoV-2 infection by treatment with viral entry inhibitors [118].